FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

2021000195106: Swiss French language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 07-Jun 2023. Module: SNOMED CT Switzerland NRC maintained Module

Descriptions:

Id Description Lang Type Status Case? Module
2061000195115 Swiss French language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
2071000195114 Swiss French language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
237201000195110 ensemble de référence pour la langue française suisse fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

303434 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Swiss French language reference set (foundation metadata concept) Is a French [International Organization for Standardization 639-1 code fr] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
4,4'-diisocyanate de diphénylméthane Preferred (foundation metadata concept)
4-(2-Hydroxy-5-methylphenylazo)acetanilide, N-[4-(2-Hydroxy-5-methylphenylazo)phenyl]acetamide Acceptable (foundation metadata concept)
4-(4-Nitrophenylazo)diphenylamine Acceptable (foundation metadata concept)
4-(4-nitrophenylazo)aniline Acceptable (foundation metadata concept)
4-ADPA - 4-aminodiphénylamine Acceptable (foundation metadata concept)
4-MBC - 4-Methylbenzylidene camphor Acceptable (foundation metadata concept)
4-Nitro-4'-(ethyl(2-hydroxyethyl)amino)azobenzène Acceptable (foundation metadata concept)
4-aminoazobenzène Preferred (foundation metadata concept)
4-aminophénol Acceptable (foundation metadata concept)
4-hydroxybenzoate d'éthyle Preferred (foundation metadata concept)
4-hydroxybenzoate de butyle Acceptable (foundation metadata concept)
4-hydroxybenzoate de méthyle Preferred (foundation metadata concept)
4-hydroxybenzoate de méthyle sodique Preferred (foundation metadata concept)
4-hydroxybenzoate de propyle Preferred (foundation metadata concept)
4-méthylaminophénol Acceptable (foundation metadata concept)
4-tert-butylcatéchol Preferred (foundation metadata concept)
40 mm Preferred (foundation metadata concept)
4e étage Acceptable (foundation metadata concept)
5 grossesses Acceptable (foundation metadata concept)
5 heures Preferred (foundation metadata concept)
5-amino-4-imidazole carboxamide ribosidurie Preferred (foundation metadata concept)
5-fluorocytosine Acceptable (foundation metadata concept)
5-hydroxyméthoxyphénamine Preferred (foundation metadata concept)
5-méthoxypsoralène Preferred (foundation metadata concept)
5-triméthoxyamphétamine Preferred (foundation metadata concept)
50 mm Preferred (foundation metadata concept)
50-80 % de spermatozoïdes de morphologie normale Acceptable (foundation metadata concept)
50^e^ au 75^e^ centile Preferred (foundation metadata concept)
57 Co-cyanocobalamine Preferred (foundation metadata concept)
58 Co-cyanocobalamine Preferred (foundation metadata concept)
5e maladie Acceptable (foundation metadata concept)
5e étage Acceptable (foundation metadata concept)
6 accouchements Preferred (foundation metadata concept)
6 grossesses Acceptable (foundation metadata concept)
6 grossesses précédentes Acceptable (foundation metadata concept)
6 heures Preferred (foundation metadata concept)
6 à 10 mitoses par 10 champs à fort grossissement, score à 2 Acceptable (foundation metadata concept)
6-MC (6-méthylcoumarine) (dans l'alcool) Acceptable (foundation metadata concept)
6-O-monoacétylmorphine Acceptable (foundation metadata concept)
6-monoacétylmorphine Preferred (foundation metadata concept)
6-méthylcoumarine (dans l'alcool) Preferred (foundation metadata concept)
60 Co-cyanocobalamine Preferred (foundation metadata concept)
6e étage Acceptable (foundation metadata concept)
7 accouchements Preferred (foundation metadata concept)
7 grossesses Acceptable (foundation metadata concept)
7 grossesses précédentes Acceptable (foundation metadata concept)
72 heures Preferred (foundation metadata concept)
75^e^ au 90^e^ centile Preferred (foundation metadata concept)
7e étage Acceptable (foundation metadata concept)
8 accouchements Acceptable (foundation metadata concept)
8 grossesses Acceptable (foundation metadata concept)
8 grossesses précédentes Acceptable (foundation metadata concept)
8 heures Preferred (foundation metadata concept)
89sr-strontium chlorure Preferred (foundation metadata concept)
8e étage Acceptable (foundation metadata concept)
9 accouchements Acceptable (foundation metadata concept)
9 grossesses Acceptable (foundation metadata concept)
9 grossesses précédentes Acceptable (foundation metadata concept)
9-fluoroprednisolone Preferred (foundation metadata concept)
9-hydroxyrispéridone Preferred (foundation metadata concept)
90 degrés Preferred (foundation metadata concept)
90Mo - molybdène 90 Acceptable (foundation metadata concept)
90^e^ au 97^e^ centile Preferred (foundation metadata concept)
93Mo - molybdène 93 Acceptable (foundation metadata concept)
93mMo - molybdène 93m Acceptable (foundation metadata concept)
99Mo - molybdène 99 Acceptable (foundation metadata concept)
99Tc - technétium 99 Acceptable (foundation metadata concept)
99mTc - technétium 99m Acceptable (foundation metadata concept)
9e étage Acceptable (foundation metadata concept)
A gamma-delta-bêta 0 thalassémie Acceptable (foundation metadata concept)
A gamma-delta-bêta zéro thalassémie Preferred (foundation metadata concept)
A-positionnement Preferred (foundation metadata concept)
A1AT (alpha-1-antitrypsine) de phénotype PiMM Acceptable (foundation metadata concept)
A1AT (alpha-1-antitrypsine) de phénotype PiMS Acceptable (foundation metadata concept)
A1AT (alpha-1-antitrypsine) de phénotype PiMZ Acceptable (foundation metadata concept)
A1AT (alpha-1-antitrypsine) de phénotype PiSS Acceptable (foundation metadata concept)
A1AT (alpha-1-antitrypsine) de phénotype PiSZ Acceptable (foundation metadata concept)
A1AT (alpha-1-antitrypsine) de phénotype PiZZ Acceptable (foundation metadata concept)
A1AT (alpha-1-antitrypsine) de phénotype nul Acceptable (foundation metadata concept)
AAMR adaptive behavior scale Preferred (foundation metadata concept)
AAN - anticorps antinucléaire Acceptable (foundation metadata concept)
AAP - antiagrégant plaquettaire Acceptable (foundation metadata concept)
AASC (anévrisme de l'artère sous-clavière) droite Acceptable (foundation metadata concept)
AASC (anévrisme de l'artère sous-clavière) gauche Acceptable (foundation metadata concept)
ABPA - aspergillose broncho-pulmonaire allergique Acceptable (foundation metadata concept)
ACAN - anticorps antinucléaire Acceptable (foundation metadata concept)
ACBS prescription Preferred (foundation metadata concept)
ACC (aplasia cutis congenita) associée à un syndrome dermoïde épibulbaire Acceptable (foundation metadata concept)
ACC (aplasia cutis congenita) d'un membre Acceptable (foundation metadata concept)
ACC (aplasia cutis congenita) de type 4 due à une malformation sous-jacente Acceptable (foundation metadata concept)
ACC (aplasia cutis congenita) de type 5 associée à un fœtus papyracé Acceptable (foundation metadata concept)
ACC (aplasia cutis congenita) de type 6 associée à une épidermolyse bulleuse Acceptable (foundation metadata concept)
ACC (aplasia cutis congenita) de type 7 due à un tératogène Acceptable (foundation metadata concept)
ACC (aplasia cutis congenita) de type 9 secondaire à un syndrome malformatif Acceptable (foundation metadata concept)
ACCC - alopécie cicatricielle centrifuge centrale Acceptable (foundation metadata concept)
ACG - artérite à cellules géantes Acceptable (foundation metadata concept)
ACHM - achromatopsie Acceptable (foundation metadata concept)
ACN - acné chéloïdienne de la nuque Acceptable (foundation metadata concept)
ACNPL - amylose cutanée nodulaire primitive localisée Acceptable (foundation metadata concept)
ACPL - amylose cutanée primitive localisée Acceptable (foundation metadata concept)
ACPS (acrocéphalopolysyndactylie) de type IV Acceptable (foundation metadata concept)

Start Previous Page 6 of 3035 Next End

Reference Sets

Reference set descriptor

Back to Start